This aligns with previous findings where telmisartan ameliorated neuropathies by increasing HO-1 levels through Nrf2 pathway activation, as evidenced by elevated Nrf2 and HO-1 expression in the kidneys of both healthy and diabetic rats (Antar et al., 2022). Here, HMOX1 is linked to neuropathy.